ESR1 and breast carcinoma: However, breast cancers that co-express ERα and human epidermal growth factor receptor 2 (HER2), HER2 alone, or triple negative breast cancers (TNBC), which do not express any hormone or growth factor receptors, are more aggressive and tougher to treat.